Pathophysiologically, patients with TTP develop thrombi composed of platelets and von Willebrand factor (vWF) caused by deficiency in the activity of plasma enzyme ADAMTS13. This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.